|
|
||||||||
Division of Dermatology, University of California, San Diego and VA Medical Center, San Diego, California, USA
1Correspondence: Mail Code 9111B, 3350 La Jolla Village Dr., San Diego, CA 92161, USA. E-mail: rgallo{at}vapop.ucsd.edu
Glycosaminoglycans, linear carbohydrates such as heparan sulfate and hyaluronan, participate in a variety of biological processes including cell-matrix interactions and activation of chemokines, enzymes and growth factors. This review will discuss progress in immunology and the science of wound repair that has revealed the importance of glycosaminoglycans, and their proteoglycans, in the inflammatory process. Heparan sulfate enables growth factor function and modifies enzyme/inhibitor functions, such as antithrombin III and heparin cofactor II. Heparan sulfate also interacts with cytokines/chemokines and participates in leukocyte selectin binding to promote the recruitment of leukocytes. Chondroitin sulfate/dermatan sulfate regulates growth factor activity and is an alternate modulator of heparin cofactor II. In addition, dermatan sulfate induces ICAM-1 expression on endothelial cells and also recruits leukocytes via selectin interactions. Hyaluronan alternatively participates in leukocyte recruitment via interaction with CD44, while activating various inflammatory cells, such as macrophages, through CD44-dependent signaling. Hyaluronan also signals through Toll-like receptor 4 to induce dendritic cell maturation and promote cytokine release by dendritic cells and endothelial cells. Taken together, the field of glycosaminoglycan biology provides new clues and explanations of the process of inflammation and suggests new therapeutic approaches to human disease.Taylor, K. R., Gallo, R. L. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation.
Key Words: heparan sulfate chondroitin sulfate dermatan sulfate hyaluronan
This article has been cited by other articles:
![]() |
H. Wang, Y. Katagiri, T. E. McCann, E. Unsworth, P. Goldsmith, Z.-X. Yu, F. Tan, L. Santiago, E. M. Mills, Y. Wang, et al. Chondroitin-4-sulfation negatively regulates axonal guidance and growth J. Cell Sci., September 15, 2008; 121(18): 3083 - 3091. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. den Dekker, S. Grefte, T. Huijs, G. B. ten Dam, E. M. M. Versteeg, L. C. J. van den Berk, B. A. Bladergroen, T. H. van Kuppevelt, C. G. Figdor, and R. Torensma Monocyte Cell Surface Glycosaminoglycans Positively Modulate IL-4-Induced Differentiation toward Dendritic Cells J. Immunol., March 15, 2008; 180(6): 3680 - 3688. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ferrari, R. Galletti, D. Pontiggia, C. Manfredini, V. Lionetti, D. Bellincampi, F. Cervone, and G. De Lorenzo Transgenic Expression of a Fungal endo-Polygalacturonase Increases Plant Resistance to Pathogens and Reduces Auxin Sensitivity Plant Physiology, February 1, 2008; 146(2): 669 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kon, M. Ikesue, C. Kimura, M. Aoki, Y. Nakayama, Y. Saito, D. Kurotaki, H. Diao, Y. Matsui, T. Segawa, et al. Syndecan-4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin J. Exp. Med., January 21, 2008; 205(1): 25 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Laabs, H. Wang, Y. Katagiri, T. McCann, J. W. Fawcett, and H. M. Geller Inhibiting Glycosaminoglycan Chain Polymerization Decreases the Inhibitory Activity of Astrocyte-Derived Chondroitin Sulfate Proteoglycans J. Neurosci., December 26, 2007; 27(52): 14494 - 14501. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Leaphart, J. Cavallo, S. C. Gribar, S. Cetin, J. Li, M. F. Branca, T. D. Dubowski, C. P. Sodhi, and D. J. Hackam A Critical Role for TLR4 in the Pathogenesis of Necrotizing Enterocolitis by Modulating Intestinal Injury and Repair J. Immunol., October 1, 2007; 179(7): 4808 - 4820. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Schenauer, Y. Yu, M. D. Sweeney, and J. A. Leary CCR2 Chemokines Bind Selectively to Acetylated Heparan Sulfate Octasaccharides J. Biol. Chem., August 31, 2007; 282(35): 25182 - 25188. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Segerer, R. Djafarzadeh, H.-J. Grone, C. Weingart, D. Kerjaschki, C. Weber, A. J. Kungl, H. Regele, A. E.I. Proudfoot, and P. J. Nelson Selective Binding and Presentation of CCL5 by Discrete Tissue Microenvironments during Renal Inflammation J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1835 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Rops, C. W. Jacobs, P. C. Linssen, J. B. Boezeman, J. F. Lensen, T. J. Wijnhoven, L. P. van den Heuvel, T. H. van Kuppevelt, J. van der Vlag, and J. H. Berden Heparan sulfate on activated glomerular endothelial cells and exogenous heparinoids influence the rolling and adhesion of leucocytes Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1070 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Li, A. K. Shetty, and K. Sugahara Neuritogenic Activity of Chondroitin/Dermatan Sulfate Hybrid Chains of Embryonic Pig Brain and Their Mimicry from Shark Liver: INVOLVEMENT OF THE PLEIOTROPHIN AND HEPATOCYTE GROWTH FACTOR SIGNALING PATHWAYS J. Biol. Chem., February 2, 2007; 282(5): 2956 - 2966. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Myint, Y. Yamamoto, T. Doi, I. Kato, A. Harashima, H. Yonekura, T. Watanabe, H. Shinohara, M. Takeuchi, K. Tsuneyama, et al. RAGE Control of Diabetic Nephropathy in a Mouse Model: Effects of RAGE Gene Disruption and Administration of Low-Molecular Weight Heparin Diabetes, September 1, 2006; 55(9): 2510 - 2522. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brule, N. Charnaux, A. Sutton, D. Ledoux, T. Chaigneau, L. Saffar, and L. Gattegno The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9 Glycobiology, June 1, 2006; 16(6): 488 - 501. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |